Circulating tumor DNA profiling reveals clonal evolution and real-time disease progression in advanced hepatocellular carcinoma

Author:

Cai Zhi-Xiong12,Chen Geng12,Zeng Yong-Yi123,Dong Xiu-Qing12,Lin Min-Jie12,Huang Xin-Hui12,Zhang Da12,Liu Xiao-Long12ORCID,Liu Jing-Feng123

Affiliation:

1. The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province; Mengchao Hepatobiliary Hospital of Fujian Medical University; Fuzhou 350025 China

2. The Liver Center of Fujian Province, Fujian Medical University; Fuzhou 350025 China

3. Liver Disease Center, The First Affiliated Hospital of Fujian Medical University; Fuzhou 350025 China

Funder

Startup Fund for scientific research, Fujian Medical University

Scientific Foundation of Fujian Health and family planning Department

Science and Technology Infrastructure Construction Program of Fujian Province

Scientific Foundation of Fujian Province

Science and Technology major project of Fuzhou

specialized Science and Technology Key Project of Fujian Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference23 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Epidemiology of hepatocellular carcinoma;Lafaro;Surg Oncol Clin N Am,2015

3. Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease;Mittal;Clin Gastroenterol Hepatol,2016

4. Management of HCC;Lope;J Hepatol,2012

5. Peritransplant lymphopenia is a novel prognostic factor in recurrence of hepatocellular carcinoma after liver transplantation;Nagai;Transplantation,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3